The Company
"We develop and license vaccines and novel technologies for vaccines and diagnostics."

Our flagship project is a patented enterovirus based preventive Type 1 Diabetes (T1D) vaccine, similar to the widely used enterovirus vaccine against polio. Our other projects include new treatments and diagnostics for Celiac Disease, all covered by patents.